Also in this playlist...
This transcript is automatically generated
Highs in the meantime the FDA is opening up -- hearing today following a very disturbing report.
About the popular diabetes drug a -- -- -- this report claims that the drug company GlaxoSmithKline.
Has known for ten years.
That of any it was riskier to the heart and other medicines but despite knowing that information.
The report claims that the drug company hid that information.
From there all of their own data from federal drug regulators and from the public after Mark Siegel a member of the Fox News medical eighteen is here.
I definitely good to have you here this morning thank you -- month by.
It's pretty disturbing -- they didn't study they wanted to compare this drug to another drug -- activists did this study some eleven years ago and during that study eleven years ago found out that it was risky to the heart.
And -- an email from a doctor -- free in this report that says these data should not see the light of day.
You know this is an accumulating.
With this particular manufacturer and this drug.
Over ten year period involving at least six clinical trials -- -- you mentioned I -- -- give a little background on this the class of drugs.
That this is one of their three drugs in this class.
One was removed from the market ten years ago it's called -- and from four closing liver problems.
This one's been under scrutiny ever since these drugs are actually greatly increase sensitivity to insulin.
And -- and allow a diabetic to get rid of sugar excess sugar and diabetes.
Doubles or triples your risk of heart disease of stroke you can imagine that we want this stroke but over the -- years we have more drugs we can use.
And this drug is really under fire and it's very disturbing -- the drug companies conduct their own trials that's already a problem.
-- that they may actually suppressed information the FBI is looking at the idea that a study called the record trial 2007.
That JFK Glaxo -- points -- pay the drug is safe way to find in a problem at the same time that -- -- sunset -- report New England Journal looked at 43%.
Increased risk of heart attack.
Now it's looking like there was at least a dozen cases of people in terrible trouble on this drug that they didn't report.
You make -- great point I mean why is the drug company doing their own tests on these drugs and if you read into this story says that you know they were going -- a little bit of a tough time didn't have a big successful drug at that moment a lot of pressure on them.
I to have a successful drug it seems that if there isn't role for the government -- regulation this this might be a pretty good -- than the start.
Also says that they had to they -- illegally.
Obligated to post it on their website the results of it grooves so to let the federal regulators now.
Oh great and there's also a division Martha within the FDA on how to handle these things.
Doctor Jenkins as part of a group.
That looks at drugs that still saying that this drug may be -- Doctor sharp -- who actually know deputy commissioner -- taken a very hard look at this my prediction this drug is gonna go off the market this week.
One of the reasons there's a little confusion here is that this is observational in other words we can't prove that of India courses these heart problems.
But it's very suspicious that lactose a similar drug doesn't seem to have these problems and thousands and thousands of people statistically much more likely that you're gonna have a heart attack.
Or stroke or problem -- your bones with this drug.
Most endocrinologist have stopped prescribing it.
I think I would not give distort my patients right now -- is actually much more commonly used but I think this drug is gonna probably thought that.
Happened to this this company as a result because that they -- patients and doctors if this is -- Of the ability to sit out attacking each other and say OK here's here's the risk of that here's this other drug that you could take that might be you know a little bit less risky they they -- that -- -- information that they should have had to make the good decision.
You know that is a great point and many lawsuits of -- started against this manufactured -- you're talking about exactly what the practice of medicine is -- sitting in front of my patience and staying.
Here's one drug here's another drug here's why I wanna use this drug rather than the other when they say -- the drug -- out in the waiting room -- -- -- this drug is probably safer I need all the information I can.
And it's really doing a disservice to doctors and patients to keep that information back.
If you happen to answers out of office.
Thank you very much that you would take you -- -- that it has that taken it.
-- -- after that I switching NIX predict over the next two days the FDA will remove the strike -- heard it here thank you very much stuck to act like we're always signals there's that we listen right now.
Filter by section